Your browser doesn't support javascript.
loading
Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy.
Gaston, Tyler E; Szaflarski, Magdalena; Hansen, Barbara; Bebin, E Martina; Szaflarski, Jerzy P.
  • Gaston TE; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, AL, USA; UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA; Birmingham VA Medical Center, Birmingham, AL, USA. Electronic address: tegaston@uabmc.edu.
  • Szaflarski M; Department of Sociology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Hansen B; Department of Sociology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Bebin EM; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, AL, USA; UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Szaflarski JP; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, AL, USA; UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Epilepsy Behav ; 95: 10-17, 2019 06.
Article en En | MEDLINE | ID: mdl-31003195

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Cannabidiol / Epilepsia Refractaria / Anticonvulsivantes Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Cannabidiol / Epilepsia Refractaria / Anticonvulsivantes Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article